These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 18781466)

  • 1. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?
    Fu M
    Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are autoantibodies against the beta1-adrenergic receptor markers for dilated cardiomyopathy?
    Arndt-Marić R; Nägele H; Schewe G; Kromminga A
    Clin Lab; 2010; 56(11-12):519-26. PubMed ID: 21141435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R; Boivin V; Lohse MJ
    Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
    Jahns R; Boivin V; Lohse MJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):20-4. PubMed ID: 16387626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological autoantibodies in cardiomyopathy.
    Jahns R; Boivin V; Schwarzbach V; Ertl G; Lohse MJ
    Autoimmunity; 2008 Sep; 41(6):454-61. PubMed ID: 18781471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
    Deubner N; Berliner D; Schlipp A; Gelbrich G; Caforio AL; Felix SB; Fu M; Katus H; Angermann CE; Lohse MJ; Ertl G; Störk S; Jahns R;
    Eur J Heart Fail; 2010 Jul; 12(7):753-62. PubMed ID: 20494925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ig apheresis for the treatment of severe DCM patients.
    Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
    Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
    Mobini R; Maschke H; Waagstein F
    Autoimmun Rev; 2004 Jun; 3(4):277-84. PubMed ID: 15246023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological importance of anti-G-protein coupled receptor autoantibodies.
    Matsui S; Fu M
    Int J Cardiol; 2006 Sep; 112(1):27-9. PubMed ID: 16870280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.
    Jahns R; Boivin V; Hein L; Triebel S; Angermann CE; Ertl G; Lohse MJ
    J Clin Invest; 2004 May; 113(10):1419-29. PubMed ID: 15146239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists?
    Hébert TE
    Cardiovasc Res; 2007 Oct; 76(1):5-7. PubMed ID: 17707357
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M; Wallukat G; Potapov E; Hetzer R
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune cardiac-specific T cell responses in dilated cardiomyopathy.
    Jane-wit D; Tuohy VK
    Int J Cardiol; 2006 Sep; 112(1):2-6. PubMed ID: 16859767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
    Castellano G; Affuso F; Di Conza P; Fazio S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.